Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

Rapamycin + Acarbose (RaAc) - Stage II

Source date not recordedAnalyse record ↗
Modality
small molecule
Kind
rate-of-aging
Tested by ITP
yes
ITP year first tested
2017
ITP median % ↑ (♂, best cohort)
37.00
ITP median % ↑ (♀, best cohort)
28.00
ITP P90 % ↑ (♂, best cohort)
24.00
ITP P90 % ↑ (♀, best cohort)
21.00
ITP sex effect
both
ITP dose (ppm)
Ra: 14.7 ppm and Ac: 1000 ppm
ITP age at start (mo)
9 mo; 16 mo
ITP replicated
no
ITP result status
Published (full stats)

ITP cohort detail (2)

YearCohortDose♂ med♀ med♂ P90♀ P90Citation
2017C2017Ra: 14.7 ppm and Ac: 1000 ppm37%28%24%21%↗ paper
2017C2017Ra: 14.7 ppm and Ac: 1000 ppm14%12%18%15%↗ paper